How COVID-19 Affects Lung Transplantation: A Comprehensive Review
Open Access
- 18 June 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (12) , 3513
Abstract
Lung transplant (LuTx) recipients are at a higher risk of developing serious illnesses from COVID-19, and thus, we have closely reviewed the consequences of the COVID-19 pandemic on lung transplantation. In most transplant centers, the overall LuTx activity significantly declined and led to a specific period of restricting lung transplantation to urgent cases. Moreover, several transplant centers reported difficulties due to the shortage of ICU capacities. The fear of donor-derived transmission generated extensive screening programs. Nevertheless, reasonable concerns about the unnecessary losses of viable organs were also raised. The overall donor shortage resulted in increased waiting-list mortality, and COVID-19-associated ARDS became an indication of lung transplantation. The impact of specific immunosuppressive agents on the severity of COVID-19 varied. Corticosteroid discontinuation was not found to be beneficial for LuTx patients. Tacrolimus concentrations were reported to increase during the SARS-CoV-2 infection, and in combination with remdesivir, tacrolimus may clinically impact renal functions. Monoclonal antibodies were shown to reduce the risk of hospitalization in SOT recipients. However, understanding the pharmacological interactions between the anti-COVID-19 drugs and the immunosuppressive drugs requires further research.Keywords
Funding Information
- Ministry of Health, Czech Republic–Conceptual Development of Research Organizatio (6028)
- Motol University Hospital, Prague, Czech Republic (6028)
- Cooperatio Program (6028)
This publication has 97 references indexed in Scilit:
- Lung Transplantation as a Therapeutic Option in Acute Respiratory Distress SyndromeTransplantation, 2018
- Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung TransplantationTransplantation, 2016
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart–Lung Transplant Report—2016; Focus Theme: Primary Diagnostic Indications for TransplantThe Journal of Heart and Lung Transplantation, 2016
- Prophylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled TrialAmerican Journal of Transplantation, 2016
- A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2015
- Long-term Outcomes of Pandemic 2009 Influenza A(H1N1)-Associated Severe ARDSChest, 2012
- Infectious Disease Transmission during Organ and Tissue TransplantationEmerging Infectious Diseases, 2012
- Mycophenolate mofetil: An updateDrugs of Today, 2009
- Corticosteroid Interactions with Cyclosporine, Tacrolimus, Mycophenolate, and Sirolimus: Fact or Fiction?Annals of Pharmacotherapy, 2008
- Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocolsThe Journal of Heart and Lung Transplantation, 2001